BioWorld Asia

April 9, 2003

Serono Signs On Graffinity As Partner For Drug Development

Graffinity AG, a specialist in preclinical drug discovery, landed a commitment from Serono SA to help fill the development pipeline of Europe's largest biotechnology company. (BioWorld International) Read More

Epigenomics Raises EUR21M To Fund Work In DNA Methylation

Angiogenesis Study Encourages Prospects In Ischemia Treatment

GeneProt Slashes Staff, Cites Current Economic Environment

Ester Neuroscience Gets Good Results In Early Antisense Trial

Chiasma Gets First Biotech Investment From InnoMed

Galapagos Enters Collaboration In Nutraceuticals With Degussa

European Officials Craft Report On Embryonic Stem Cell Research

SR Pharma Taking Stock After Acquiring Rodaris, Joint Venture

EBML Targets Young Companies In Europe With New EUR25M Fund

Bioline Therapeutics Formed By Israeli Groups With $11M Funding

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

mRNA vaccines are composed of messenger RNA encapsulated in lipid nanoparticles

mRNA flu vaccine can activate broad germinal center response

BioWorld

On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...

GLP-1s need technologies for long-term use

BioWorld

For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...

UTRN gene involved in arthrogryposis, study finds

BioWorld Science

Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...